Atara Biotherapeutics
ATRA
#9237
Rank
ยฃ77.59 M
Marketcap
ยฃ10.76
Share price
0.92%
Change (1 day)
7.02%
Change (1 year)

Revenue for Atara Biotherapeutics (ATRA)

Revenue in 2025 (TTM): ยฃ0.14 Billion

According to Atara Biotherapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ0.14 Billion. In 2024 the company made a revenue of ยฃ0.10 Billion an increase over the revenue in the year 2023 that were of ยฃ6.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atara Biotherapeutics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.14 B41.03%
2024 ยฃ0.10 B1426.9%
2023 ยฃ6.72 M-87.19%
2022 ยฃ52.54 M248.73%
2021 ยฃ15.06 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Agenus
AGEN
ยฃ80.22 M-43.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
ยฃ0.72 M-99.49%๐Ÿ‡ฉ๐Ÿ‡ช Germany
ImmunoGen
IMGN
ยฃ0.21 B 52.45%๐Ÿ‡บ๐Ÿ‡ธ USA